Research
Hormonal
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) help manage type 2 diabetes mellitus (T2DM) by controlling blood sugar and promoting weight loss.
GLP-1RAs can be considered as a treatment option for patients with T2DM who need to manage blood sugar and weight.
StrongSupportsmedium confidence
GLP-1RAs were initially introduced as a rising star for managing T2DM, with patients benefiting from the control of blood sugar and weight loss.
Why this rating
The abstract discusses the established role of GLP-1RAs in clinical practice.
Source
Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions
Alaa Ismail et al. · World Journal of Gastrointestinal Pharmacology and Therapeutics · 2025
reviewCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →